- Home
- IPHA vs RAIL Comparison
IPHA vs RAIL Comparison
Compare IPHA & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- RAIL
- Stock Information
- Founded
- IPHA 1999
- RAIL 1901
- Country
- IPHA France
- RAIL United States
- Employees
- IPHA N/A
- RAIL N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- RAIL Railroads
- Sector
- IPHA Health Care
- RAIL Industrials
- Exchange
- IPHA Nasdaq
- RAIL Nasdaq
- Market Cap
- IPHA 160.1M
- RAIL 187.4M
- IPO Year
- IPHA 2019
- RAIL N/A
- Fundamental
- Price
- IPHA $2.16
- RAIL $8.54
- Analyst Decision
- IPHA Strong Buy
- RAIL
- Analyst Count
- IPHA 1
- RAIL 0
- Target Price
- IPHA $11.00
- RAIL N/A
- AVG Volume (30 Days)
- IPHA 6.4K
- RAIL 229.4K
- Earning Date
- IPHA 09-17-2025
- RAIL 08-04-2025
- Dividend Yield
- IPHA N/A
- RAIL N/A
- EPS Growth
- IPHA N/A
- RAIL N/A
- EPS
- IPHA N/A
- RAIL N/A
- Revenue
- IPHA $20,831,349.00
- RAIL $465,864,000.00
- Revenue This Year
- IPHA $350.96
- RAIL $2.94
- Revenue Next Year
- IPHA $32.92
- RAIL $6.56
- P/E Ratio
- IPHA N/A
- RAIL N/A
- Revenue Growth
- IPHA N/A
- RAIL N/A
- 52 Week Low
- IPHA $1.29
- RAIL $4.31
- 52 Week High
- IPHA $3.51
- RAIL $16.10
- Technical
- Relative Strength Index (RSI)
- IPHA 52.85
- RAIL 41.65
- Support Level
- IPHA $2.04
- RAIL $8.53
- Resistance Level
- IPHA $2.20
- RAIL $8.95
- Average True Range (ATR)
- IPHA 0.10
- RAIL 0.44
- MACD
- IPHA -0.02
- RAIL 0.01
- Stochastic Oscillator
- IPHA 33.83
- RAIL 43.18
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About RAIL FreightCar America Inc.
FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.